Donna-Beth Howe# QUERY93bf184ea67c66d3327d5fddecb4f8c7
Donna-Beth Howe# QUERYa6e222de17bd13570b3f85f2655dd9dc
Donna-Beth Howe# QUERY4661cb5829a7b84d67d4e26730bbf102
Donna-Beth Howe# QUERYe9e815241aaae7390711737d16a70373
Donna-Beth Howe OR Donna-Beth Howe
Donna-Beth Howe# QUERY7f9aa1c99a7df53de82129702c2b1169
Donna-Beth Howe# QUERY04f4062ca7381942169a1e498bc452e7
Donna-Beth Howe# QUERY1ae0e352ebf128e2389b856335519699
Donna-Beth Howe
Donna-Beth Howe# QUERY27a847d62eeda26603fbaf19c49d3020
NRC/NMSS/MSST/MSEB/MRST false
Donna-Beth Howe# QUERY059f34babceb9322548ef0596d87e9a4
NRC/NMSS/MSST/MSEB/MRST true
Donna-Beth Howe# QUERY68c6f09272f5d0023f188862b78b67f5
NRC Headquarters
Donna-Beth Howe# QUERYde076fd0735aa8b856faf204727da28d
RIS 2003-17, Complying with 10 CFR 35.59, Recentness of Training, for Board-Certified Individuals Whose Training and Experience Were Completed More than 7 Years Ago
RIS 2006-27, Availability of NRC 313A Series of Forms and Guidance for Their Completion
RIS 2005-23, Clarification of the Physical Presence Requirement During Gamma Stereotactic Radiosurgery Treatments
Information Notice 2017-02, Best Practices Concepts for Patient Release
Information Notice 2007-25, Recommendations from the Advisory Committee on the Medical Use of Isotopes for Improved Compliance with 10 CFR 35.40 and 35.27
Information Notice 2007-25, Recommendations From the Advisory Committee on the Medical Use of Isotopes for Improved Compliance with 10 CFR 35.40 and 35.27
Information Notice 2004-02, Strontium-90 Eye Applicators: New Calibration Values and Use
Information Notice 2003-22, Heightened Awareness for Patients Containing Detectable Amounts of Radiation from Medical Administrations
RIS 2013-12, Notice of Issuance of Enforcement Guidance Memo-Interim Guidance for Dispositioning Violations Involving 10 CFR 35.60 & 10 CFR 35.63 for the Calibration of Instrumentation to Measure the Activity of Rb-82 and the Determ. of Rb-82 Pt Dosa
Information Notice 1988-15, Availability of Us Food & Drug Administration (Fda) Approved Potassium Iodide for Use in Emergencies Involving Radioactive Iodine
Information Notice 1988-15, Availability of Us Food & Drug Administration (FDA) Approved Potassium Iodide for Use in Emergencies Involving Radioactive Iodine
Information Notice 2002-19, Medical Misadministrations Caused by Failure to Properly Perform Tests on Dose Calibrators for Beta-and-Low-Energy Photon-Emitting Radionuclides
Information Notice 2001-08, Supplment 2: Medical Device Safety Alert Issued, Following Radiation Therapy Overexposures in Panama, and Availability of the International Atomic Energy Agency Report
Information Notice 2000-19, Implementation of Human Use Research Protocols Involving U.S. Nuclear Regulatory Commission Regulated Materials
PMNS20181177, Notification of Public Meeting on the Final 10 CFR Parts 30, 32, and 35 Rule
PMNS20181176, Notification of Public Meeting on the Final 10 CFR Parts 30, 32, and 35 Rule
PMNS20181169, Notification of Public Meeting on the Final 10 CFR Parts 30, 32, and 35 Rule
PMNS20190186, Notification of Public Meeting on the Final 10 CFR Parts 30, 32, and 35 Rule
PMNS20190256, Notification of Public Meeting on the Final 10 CFR Parts 30, 32, and 35 Rule
PMNS20190727, Exubrion Therapeutics, Inc Public Meeting
Information Notice 2019-11, Strontium-82/Rubidium-82 Generator Elution Events and Issues
NUREG-1535, Transcript of 951031 Mit Incident Investigation Team Interview of J Dwyer.Pp 1-74.W/related Info
IA-96-516, Final Response for FOIA Request for Documents.Forwards Documents Listed in App a in Entirety.App B Documents Being Released in Part (Ref FOIA Exemption 6)
IA-89-205, Rev 1 to Reg Guide 10.9, Guide for Preparation of Applications for Use of Self-Contained Dry Source-Storage Gamma Irradiators. Related Documentation Encl,Including Copyright Matl
STC-20-068, Agreement State Letter Northstar COVID-19 Addendum to Licensing Guidance
STC-20-006, Letter Transmitting Radiogenix Generator Guidance Revision 1
STC-19-015, Training Notification to Agreement States and Licensees 2 7 2019
RIS 2015-18, Sodium Iodide-131 (I-131) Patient Release Information Collection Request
PMNS20151871, Notice of Sodium Iodine I-131 Patient Release Information Collection Public Workshop
RIS 2006-19, Availability of Guidance on Radioactive Seed Localization
NUREG-1556 Volume 9, Rev. 3, Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Medical Use Licenses Final Report
GL-705652-26, GLTS: Past Due General License Device Annual Registration:GL-705652-26 Simplot Phosphates, LLC
GL-705652-24, GLTS: Past Due General License Device Annual Registration: Simplot Phosphates LLC (GL-705652-24)